Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III�…

K Murakami, Y Sakurai, M Shiino, N Funao…�- Gut, 2016 - gut.bmj.com
Objective The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter�…
Save Cite Cited by 442 Related articles

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III�…

K Murakami, Y Sakurai, M Shiino, N Funao… - 2016 - cabidigitallibrary.org
Objective: The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter�…
Cite

[CITATION][C] Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a�…

K Murakami, Y Sakurai, M Shiino, N Funao…�- Gut, 2016 - cir.nii.ac.jp
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and
second-line triple therapy for<i>Helicobacter pylori</i>eradication: a phase III, randomised�…
Cite
[PDF] darmzentrum-bern.ch

[PDF][PDF] Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase�…

K Murakami, Y Sakurai, M Shiino, N Funao…�- Workshop�…, 2014 - darmzentrum-bern.ch
Objective The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter�…
Cite
[PDF] bmj.com

[PDF][PDF] Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase�…

K Murakami, Y Sakurai, M Shiino, N Funao…�- Gut, 2016 - gut.bmj.com
Objective The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter�…
Cite
[HTML] nih.gov

[HTML][HTML] Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a�…

K Murakami, Y Sakurai, M Shiino, N Funao…�- Gut, 2016 - ncbi.nlm.nih.gov
Objective The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter�…
Cite

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III�…

K Murakami, Y Sakurai, M Shiino, N Funao…�- Gut, 2016 - europepmc.org
Objective The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter�…
Cite

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III�…

K Murakami, Y Sakurai, M Shiino, N Funao…�- Gut, 2016 - search.proquest.com
Objective The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter�…
Cite

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III�…

K Murakami, Y Sakurai, M Shiino, N Funao…�- Gut, 2016 - pubmed.ncbi.nlm.nih.gov
Objective The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter�…
Cite
[PDF] cyberleninka.org

[PDF][PDF] Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase�…

K Murakami, Y Sakurai, M Shiino, N Funao…�- Workshop�…, 2014 - cyberleninka.org
Objective The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter�…
Cite